Steven L Bernstein Selected Research

9-deoxy-delta-9-prostaglandin D2

1/2021	Approaches to Potentiated Neuroprotective Treatment in the Rodent Model of Ischemic Optic Neuropathy.
11/2013	Sustained neuroprotection from a single intravitreal injection of PGJ2 in a rodent model of anterior ischemic optic neuropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven L Bernstein Research Topics

Disease

15	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 12/2021 - 10/2007
7	Ischemia 01/2021 - 10/2003
6	Opioid-Related Disorders (Opiate Addiction) 01/2021 - 04/2015
6	Infarction (Infarctions) 01/2012 - 10/2007
5	Neoplasms (Cancer) 01/2022 - 01/2020
5	Edema (Dropsy) 01/2021 - 11/2013
4	Tobacco Use Disorder (Nicotine Dependence) 11/2021 - 02/2006
4	Stroke (Strokes) 01/2016 - 10/2003
3	Wounds and Injuries (Trauma) 11/2022 - 01/2019
3	Infections 01/2022 - 03/2005
3	Pain (Aches) 08/2021 - 03/2006
3	Substance-Related Disorders (Drug Abuse) 12/2014 - 11/2009
2	Inflammation (Inflammations) 11/2019 - 12/2013
2	Glaucoma 11/2019 - 03/2006
2	Opiate Overdose 04/2019 - 11/2018
1	Chronic Disease (Chronic Diseases) 01/2021
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2021
1	Hypotension (Low Blood Pressure) 01/2020
1	Nausea 01/2019
1	Neuroinflammatory Diseases 01/2017
1	Personality Disorders (Personality Disorder) 04/2016
1	Atrophy 02/2016
1	Retinal Hemorrhage 12/2015
1	Optic Nerve Diseases (Optic Neuropathy) 01/2015
1	Hypoventilation 01/2015
1	Optic Nerve Injuries 01/2015
1	Ganglion Cysts (Ganglion) 01/2015
1	Hypertension (High Blood Pressure) 09/2013
1	Bipolar Disorder (Manic Depressive Psychosis) 09/2013
1	Psychotic Disorders (Schizoaffective Disorder) 09/2013
1	Hyperlipidemias (Hyperlipidemia) 09/2013
1	Mental Disorders (Mental Disorder) 09/2013
1	Alcoholism (Alcohol Abuse) 01/2013
1	Macular Degeneration (Age-Related Maculopathy) 01/2013
1	Thrombosis (Thrombus) 05/2011
1	type 1D Usher syndrome 09/2009
1	Retinal Degeneration 09/2009
1	Pneumonia (Pneumonitis) 01/2009

Drug/Important Bio-Agent (IBA)

9	Retinaldehyde (Retinal)IBA 01/2021 - 10/2003
6	Pharmaceutical PreparationsIBA 11/2022 - 11/2009
6	SmokeIBA 01/2021 - 02/2006
4	Opioid Analgesics (Opioids)IBA 01/2021 - 09/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 03/2005
3	Buprenorphine (Subutex)FDA LinkGeneric 11/2017 - 04/2015
3	Neuroprotective AgentsIBA 01/2016 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 09/2009 - 10/2003
2	9-deoxy-delta-9-prostaglandin D2IBA 01/2021 - 11/2013
2	Naloxone (Narcan)FDA LinkGeneric 04/2019 - 11/2018
2	CytokinesIBA 01/2017 - 12/2013
2	Coloring Agents (Dyes)IBA 05/2011 - 04/2009
2	Rose BengalIBA 08/2010 - 04/2009
2	Messenger RNA (mRNA)IBA 09/2009 - 10/2003
1	Nogo ReceptorsIBA 12/2021
1	Monoclonal AntibodiesIBA 12/2021
1	Analgesics (Analgesic Drugs)IBA 08/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	lipoarabinomannan (LAM)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Hypnotics and Sedatives (Sedatives)IBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 11/2019
1	trabodenosonIBA 11/2019
1	AntiemeticsIBA 01/2019
1	RV 538 (PDMP)IBA 01/2018
1	Minocycline (Cyclops)FDA LinkGeneric 01/2017
1	Ion Channels (Ion Channel)IBA 01/2016
1	Glyburide (Glibenclamide)FDA LinkGeneric 01/2016
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2016
1	Dendrimers (Dendrons)IBA 01/2016
1	Sulfonylurea ReceptorsIBA 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2015
1	Fluorescein (Funduscein)FDA LinkGeneric 12/2015
1	Ranibizumab (Lucentis)FDA Link 12/2015
1	IonsIBA 05/2015
1	Naloxone Drug Combination Buprenorphine FDA Link 04/2015
1	Ciliary Neurotrophic Factor (CNTF)IBA 01/2015
1	Oxygen (Dioxygen)IBA 01/2015
1	ProstaglandinsIBA 10/2014
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2013
1	Varenicline (Chantix)FDA Link 09/2013
1	Complement Factor H (Factor H)IBA 01/2013
1	Illicit Drugs (Recreational Drugs)IBA 01/2013
1	fibulinIBA 01/2013
1	Cholinergic Agents (Cholinergics)IBA 02/2011
1	GAP-43 Protein (GAP 43 Protein)IBA 08/2010
1	Cadherins (E-Cadherin)IBA 09/2009
1	Protein Isoforms (Isoforms)IBA 09/2009
1	Fluorescein-5-isothiocyanate (FITC)IBA 08/2008
1	AnnexinsIBA 08/2008
1	Estrogens (Estrogen)FDA Link 10/2007

Therapy/Procedure

3	Intravitreal Injections 12/2015 - 11/2013
3	Lasers (Laser) 05/2011 - 04/2009
2	Nicotine Replacement Therapy 11/2021 - 01/2018
2	Operative Surgical Procedures 01/2021 - 01/2021
1	Palliative Care (Palliative Therapy) 01/2022
1	Length of Stay 01/2022
1	Hospice Care (Care, Bereavement) 01/2022
1	Patient Readmission 08/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Therapeutics 01/2016
1	Time-to-Treatment 01/2009